Guzick D S, Zeleznik A
Department of Obstetrics and Gynecology, Magee-Womens Hospital, Pittsburgh, Pennsylvania 15213.
Fertil Steril. 1990 Aug;54(2):206-10. doi: 10.1016/s0015-0282(16)53690-5.
We tested the hypothesis that the efficacy of clomiphene citrate (CC) in the treatment of luteal phase defect (LPD) is related more to the number of ovulatory follicles than to the quality of a single follicle. Eighteen ovulatory women with LPD as defined by endometrial biopsies that lagged behind chronological dates by at least 3 days on two separate menstrual cycles were studied. During the menstrual cycle before treatment and also during a treatment cycle (100 mg of CC, on days 5 to 9), we obtained an endometrial biopsy 9 to 12 days after ovulation. All biopsies were read in a blinded fashion by the same gynecological pathologist. During the treatment cycle, 10 women had more than one preovulatory follicle (greater than 15 mm, mean of three dimensions), while 8 had one preovulatory follicle. Luteal phase defect was corrected according to biopsy in 8 of the 10 women with more than one preovulatory follicle, but in only 2 of the 8 women with a single preovulatory follicle.
枸橼酸氯米芬(CC)治疗黄体期缺陷(LPD)的疗效与排卵卵泡的数量关系更大,而非单个卵泡的质量。对18名排卵型女性进行了研究,这些女性经子宫内膜活检确诊为LPD,即两个独立月经周期的子宫内膜活检结果比按时间推算的日期至少落后3天。在治疗前的月经周期以及治疗周期(第5至9天服用100 mg CC)中,我们在排卵后9至12天进行了子宫内膜活检。所有活检标本均由同一位妇科病理学家在不知情的情况下进行判读。在治疗周期中,10名女性有不止一个排卵前卵泡(三维平均直径大于15 mm),而8名女性有一个排卵前卵泡。根据活检结果,10名有不止一个排卵前卵泡的女性中有8名的黄体期缺陷得到纠正,而8名只有一个排卵前卵泡的女性中只有2名的黄体期缺陷得到纠正。